Q'Apel Medical Achieves Milestone with FDA Clearance for Zebra Neurovascular Access System
Q'Apel Medical, a pioneering private medical device firm focused on enhancing neurovascular interventions, has announced its latest achievement: the U.S. Food and Drug Administration (FDA) clearance for the Zebra Neurovascular Access System. This innovative system is specifically designed to facilitate the introduction of interventional devices into both peripheral and neurovascular systems, addressing a critical need in the medical community.
The clearance encompasses two sizes—6F and 7F—making the Zebra system suitable for a variety of clinical scenarios. The demand for effective neurovascular interventions continues to escalate, driven by an aging population and increasing instances of neurovascular conditions like strokes and cerebral aneurysms. These conditions often require intricate procedures that pose significant challenges due to the anatomical complexity in such areas. Traditional catheters may fall short in balancing support and flexibility, which is essential in delicate neurovascular environments.
During a recent statement, Dr. Jan-Karl Burkhardt, the Division Head of Cerebrovascular Surgery at Penn Medicine, expressed his optimism about the Zebra system: _"I continue to be impressed by Zebra's dynamic flexibility with each additional case. Its hallmark stripes provided stable support and maintained pushability throughout my procedures. I look forward to the versatility this novel design offers and expect it to become a mainstay for my neurovascular access cases."_
The Zebra system stands out due to its distinctive design, utilizing a single full-length hypotube with a unique pattern of laser-cut stripes. This innovative construction not only enhances the catheter's flexibility from tip to tail but also ensures optimal support where needed. The advanced inner diameter (ID) to outer diameter (OD) ratio maximizes the inner lumen while eliminating ledges, enhancing both performance and procedural versatility.
With the 7F size accommodating 0.072” aspiration catheters and the 6F design further expanding product compatibility, the Zebra Neurovascular Access System is geared to meet the complex demands of modern neurovascular procedures. _“The Zebra Neurovascular Access System was engineered to easily track through the tight bends of this delicate anatomy while maintaining lumen integrity, allowing for atraumatic deliverability in neurovascular applications,”_ said Q'Apel Medical's Chief Technology Officer, Jeff Krolik.
As part of its market launch strategy, Q'Apel Medical will showcase the Zebra Neurovascular Access System at the upcoming Society for Neurointerventional Surgery (SNIS) conference, scheduled from July 14-18 in Nashville, Tennessee, at Booth 409. This event presents a unique opportunity for healthcare professionals to engage with Q'Apel’s latest offering, which promises to set a new standard in neurovascular access.
The development of the Zebra Neurovascular Access System exemplifies Q'Apel Medical's commitment to transforming neurovascular interventions. By addressing the intricacies of contemporary neurovascular challenges, the company is dedicated to delivering innovative solutions that significantly improve clinical outcomes. Q'Apel continues to engage with neurovascular specialists in developing high-quality, uniquely engineered products, ensuring that they not only meet current needs but also adapt to future advancements in the field. For further details, interested parties can visit
Q'Apel Medical's website.